Abstract
Chronic obstructive pulmonary disease (COPD) is a disease state characterized by airflow limitation that is not fully reversible caused by a noxious agent. COPD is the fourth leading cause of mortality and affects more than 16 million people in the United States, a number that has increased about 40% since 1982. As COPD and other cigarette-related diseases become epidemic worldwide, the biology of emphysema is clearly complex and poorly understood with limited translation into effective pharmacotherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected References
Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272:1497–1505.
Chapman H, Riese R, Shi G-P. Emerging roles for cysteine proteinases in tissue injury. Annu Rev Physiol 1997;59:63–88.
D’Armiento J, Dalal SS, Okada Y, Berg RA, Chada K. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 1992;71:955–961.
Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Macrophage elastase is required for the development of emphysema induced by cigarette smoke in mice. Science 1997;277:2002–2004.
Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000 106:1311–1319.
Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2000;51:1–16.
Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med 1997; 6:675–677.
Mecham RP, Davis EC. Elastic fiber structure and assembly. In: Yurchenko P, Birk D, Mecham R, eds. Extracellular Matrix Assembly and Structure. San Diego: Academic Press, 1994; pp. 281–314.
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (Gold) Workshop summary. Am J Respir Crit Care Med 2001;163:1256–1276.
Retamales I, Elliott WM, Meshi B, et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001;164:469–473.
Shapiro S. The macrophage in chronic obstruction pulmonary disease. Am J Respir Crit Care Med 2000;160(5 Pt 2):S29–S32.
Stockley RA. Proteases and antiproteases. Novartis Found Symp 2000; 234:189–199; discussion 199-204.
Silverman EK. Hereditary pulmonary emphysema. In: Rimoin DL, Connor M, Pyeritz RE, Korf BR, Emery AE, eds. Emery and Rimoin’s Principles and Practice Of Medical Genetics. 4th ed., London: Churchill Livingstone, 2002.
Wright JL. Emphysema: Concepts under change-a pathologist’s perspective. Mod Pathol 1995;8:873–880.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this chapter
Cite this chapter
Shapiro, S.D. (2006). Pulmonary Emphysema. In: Runge, M.S., Patterson, C. (eds) Principles of Molecular Medicine. Humana Press. https://doi.org/10.1007/978-1-59259-963-9_23
Download citation
DOI: https://doi.org/10.1007/978-1-59259-963-9_23
Publisher Name: Humana Press
Print ISBN: 978-1-58829-202-5
Online ISBN: 978-1-59259-963-9
eBook Packages: MedicineMedicine (R0)